Azzam, M.M.; Hussein, A.M.; Marghani, B.H.; Barakat, N.M.; Khedr, M.M.M.; Heakel, N.A.
Retinoic Acid Potentiates the Therapeutic Efficiency of Bone Marrow-Derived Mesenchymal Stem Cells (BM-MSCs) against Cisplatin-Induced Hepatotoxicity in Rats. Sci. Pharm. 2022, 90, 58.
https://doi.org/10.3390/scipharm90040058
AMA Style
Azzam MM, Hussein AM, Marghani BH, Barakat NM, Khedr MMM, Heakel NA.
Retinoic Acid Potentiates the Therapeutic Efficiency of Bone Marrow-Derived Mesenchymal Stem Cells (BM-MSCs) against Cisplatin-Induced Hepatotoxicity in Rats. Scientia Pharmaceutica. 2022; 90(4):58.
https://doi.org/10.3390/scipharm90040058
Chicago/Turabian Style
Azzam, Maha M., Abdelaziz M. Hussein, Basma H. Marghani, Nashwa M. Barakat, Mohsen M. M. Khedr, and Nabil Abu Heakel.
2022. "Retinoic Acid Potentiates the Therapeutic Efficiency of Bone Marrow-Derived Mesenchymal Stem Cells (BM-MSCs) against Cisplatin-Induced Hepatotoxicity in Rats" Scientia Pharmaceutica 90, no. 4: 58.
https://doi.org/10.3390/scipharm90040058
APA Style
Azzam, M. M., Hussein, A. M., Marghani, B. H., Barakat, N. M., Khedr, M. M. M., & Heakel, N. A.
(2022). Retinoic Acid Potentiates the Therapeutic Efficiency of Bone Marrow-Derived Mesenchymal Stem Cells (BM-MSCs) against Cisplatin-Induced Hepatotoxicity in Rats. Scientia Pharmaceutica, 90(4), 58.
https://doi.org/10.3390/scipharm90040058